Boswellia serrata extract scores well in COX-2 comparison

[Guest guest]

From NWFP newsletter :

http://www.fao.org/forestry/site/nwfp/en/

LLx

 

8. Boswellia serrata extract scores well in COX-2 comparison

 

Source: NutraIngredients-usa.com, France, 20 March 2007

 

 

 

Boswellia serrata extract performed as well as a selective COX-2

inhibitor in a controlled clinical study to assess its effect on

relieving osteoarthritis pain, researchers report in the Journal of

Indian Pharmacology. (S Sontakke, V Thawani, S Pimpalkhute, P Kabra, S

Babhulkar, L. Hingorani. 2007. Open, randomized, controlled clinical

trial of Boswellia serrata extract as compared to valdecoxib in

osteoarthritis of knee. Indian Journal of Pharmacology. February 2007,

vol 39, issue 1, 27-9)

 

Boswellia serrata has a long history of use in Ayurvedic

medicine, popular in India, and its gum resin is reputed to have

anti-inflammatory, anti-arthritic, and analgesic activities.

 

Although in a randomized, double-blind clinical controlled

study Boswellia serrata extract was reported to be better than a

placebo in relieving osteoarthritis symptoms in the knee, researchers

at the Government Medical College in Nagpur decided to conduct the new

research since no comparative clinical trial using the extract has

been reported.

 

Their positive findings give further backing to the

efficacy of the extract in addressing joint health - an area in which

patients have been casting about for natural alternatives to COX-2

inhibitors following revelations about serious adverse events and

subsequent withdrawals.

 

For full story, please see:

http://www.nutraingredients-usa.com/news/ng.asp?n=75124-boswellia-serrata-cox-jo\

int-health